The RBV Blog

The people, products, and ideas shaping healthcare today – by Dr. Richard Vanderveer, Chief Innovation Officer, ThinkGen

Richard Vanderveer, Ph.D.

Richard Vanderveer, Ph.D.

In addition to his blog, Dr. Vanderveer has written numerous articles on innovation in healthcare marketing and marketing research - not only to challenge new thinking, but also to provide specific and practical advice.

When Is Cheaper Not???

Check this out. Yup. EpiPen pricing again. We haven’t talked about this inflammatory issue in quite some time. But here we go again. Strange back story here. The FDA proudly announced that in approving a TEVA generic for EpiPen, it was offering the public a “lower-cost...

Continue reading

Insurance Denial

A week or so ago we talked about the “joys” of insurance companies requiring “preauthorization” for the use of medications. At the proverbial Bottom Line, we pondered the impact that delays and other short circuits could have on the quality of the medical care delivered....

Continue reading

Risky Signatures

Check this out. What you will see is an unfortunate farce, one of many in U.S. healthcare in 2018. More specifically , you will see a blog post that points out the risk of physicians blindly “signing off” on charts of care provided to patients by PA’s and NP’s. Couple...

Continue reading

Paying Attention To Patient Modesty

Interesting. In the years I have been writing this blog, I don’t believe that I have typed in the word “modesty” even once. BUT. Check this out. What you will see is the home page of an organization (?) dedicated to patient modesty. Spend some time hitting the various...

Continue reading

Death By Prior Authorization

Huh? Check this out. What you will see is a very disturbing blog post. In it, you will see reportage of a case in which a patient died due to an insurance company’s inability/unwillingness to authorize a life-saving anti-seizure medication on a timely basis....

Continue reading